Back to RecallTracker
Health Canada Medical devices

Fetalscreen II

Issued August 15, 2024
Issue
A customer complaint investigation has confirmed that the lot of Fetalscreen II stated above shows unexpected macroscopic reactivity (agglutination) when performing QC testing with the positive control cells. This will impact the reading of rosettes to validate the positive control and may impact the reading of positive tests, potentially resulting in false negative results. Recall Start Date: July 22, 2024
Hazard description
Performance
Product
Product name
Fetalscreen II
Reference
ID
RA-75924